CellMosaic, Inc. is a leading biotechnology company based in Woburn, MA, specializing in the development and manufacturing of Antibody Drug Conjugate ADC Kits and AqT bioconjugates. They offer a diverse range of products and services for bioconjugation drug development and manufacturing, with a focus on advancing AqT technologies to address biocompatibility and toxicity challenges in bioconjugates and biopharmaceuticals.
Under the leadership of Dr. Huang and Dr. Dey, CellMosaic has secured multiple patents, launched innovative products, and gained recognition for their breakthrough technologies. Committed to providing cutting-edge solutions for the biopharmaceutical industry, CellMosaic is at the forefront of the fast-growing ADC market.